SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-092269
Filing Date
2009-04-29
Accepted
2009-04-29 17:29:20
Documents
4
Period of Report
2009-05-29
Effectiveness Date
2009-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 687517
2 GRAPHIC g51264g03n83.jpg GRAPHIC 101042
3 GRAPHIC g51264g37n39.jpg GRAPHIC 27042
4 GRAPHIC g51264g51a90.jpg GRAPHIC 139182
  Complete submission text file 0001193125-09-092269.txt   1057637
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 09780273
SIC: 2834 Pharmaceutical Preparations